Friday, July 6, 2018

MissionIRNewsBreaks – Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) Subsidiary Advances in Canadian Cannabis Market


Vertically integrated cannabis company Sunniva’s (CSE: SNN) (OTCQX: SNNVF) wholly-owned subsidiary, Sunniva Medical Inc. (“SMI”), received a Confirmation of Readiness (“COR”) notification from Health Canada recently. Attaining the COR is a key step toward SMI receiving a license to produce. A recent article discussing the company reads: “The COR received by Sunniva Medical Inc. (SMI) was issued under new rules instituted in May 2017 by Health Canada under the Access to Cannabis for Medical Purposes Regulations (ACMPR), which removed the necessity for a physical inspection of grow facilities prior to the issuance of a cultivation license. The new regime allows an applicant for a producer license to prove ‘their facility’s readiness in the form of data, photos, video, attestations from experts, etc.’, which, after review, can lead to the issue of a cultivation license. Designed to streamline the application process, the amended regulations do not remove the requirement for physical inspections entirely, but appear to place them on a scheduled timetable rather than before approval.”

To view the full article, visit http://ibn.fm/pnkG1

About Sunniva Inc.

Sunniva, through its subsidiaries, is a vertically integrated cannabis company operating in the world’s two largest cannabis markets – Canada and California – where we are committed to delivering safe, high-quality products and services at scale. Our vision is to become the lowest cost, highest quality cannabis producer in the markets we serve by building large scale purpose-built current Good Manufacturing Practice (“cGMP”) designed greenhouses, offering better quality assurance with cannabis products free from pesticides, providing better patient and doctor access to cannabis education and sourcing better therapeutic delivery devices. Sunniva’s management and board of directors have a proven track record for creating significant shareholder value both in the healthcare and biotech industries. For more information, visit the company’s website at www.Sunniva.com.

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html